Coherus Biosciences | CHRS - Créances Commerciales





Créances Commerciales Changement Date
AbbVie USD 12.77B 132M 2025-09
Acadia Pharmaceuticals USD 148.23M 8.79M 2025-12
Akebia Therapeutics USD 47.03M 19.19M 2025-12
ALKERMES USD 334.02M 21.08M 2025-12
Alnylam Pharmaceuticals USD 777.57M 187.2M 2025-12
Amarin USD 126.83M 477K 2025-12
Amgen USD 9.57B 1.08B 2025-12
Baxter International USD 2.01B 231M 2025-12
Biogen USD 1.85B 234M 2025-09
BioMarin Pharmaceutical USD 908.21M 117.95M 2025-12
Bristol-Myers Squibb USD 14.62B 485M 2025-09
Coherus Biosciences USD 18.42M 232.08M 2025-12
Eli Lilly USD 19.46B 2.25B 2025-09
Fujifilm JPY 822.64B 36.85B 2025-12
Gilead Sciences USD 4.91B 182M 2025-12
Ironwood Pharmaceuticals USD 81.89M 5.68M 2024-12
Merck USD 12.12B 596M 2025-09
Myriad Genetics USD 115.3M 2.7M 2025-12
Pacira USD 124.07M 8.8M 2025-12
Perrigo USD 612.8M 31.6M 2025-12
Pfizer USD 18.12B 2.02B 2025-09
PTC Therapeutics USD 181.62M 21.45M 2025-12
Regeneron Pharmaceuticals USD 5.74B 54M 2025-12
Sarepta Therapeutics USD 398.23M 2.49M 2025-12
Teva Pharmaceutical Industries USD 3.71B 101M 2025-12
Vertex Pharmaceuticals USD 2.05B 106.4M 2025-12
Xencor USD 29.3M 7.49M 2025-12
Zoetis USD 1.59B 49M 2025-12